Analyst Ratings for Insmed (INSM)
INSM Rating Summary
INSM Price Target Summary
- Highest: $263.00 (Rothschild Redburn)
- Lowest: $160.00 (Evercore ISI)
- Average: $208.87
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$208.87 (+71.9%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | BMO Capital | Connor Mackay | New Coverage | Outperform (N/A) |
192.00 (N/A) |
108.32 (121.51) |
12.18% | Details |
| 5/20/2026 | JPMorgan » Updated 8/10/2026 |
Jessica Fye | New Coverage | Overweight (N/A) |
175.00 (179.00) |
107.15 (121.51) |
13.4% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
